Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Maiorano
Alison Rae Maiorano, San Francisco, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20110088086 | LOCKING AND UNLOCKING OF AN ELECTRONIC DEVICE USING A SLOPED LOCK TRACK - Systems, apparatuses, and methods that can facilitate securing an electronic device and associated information are presented. A security component facilitates display and operation of a lock track comprising a locked portion having a positive slope and an unlocked portion, including a chasm, that is adjacent to a high point of the positive-sloped unlocked portion of the lock track. A lock facilitator component (LFC) can be moved along the track between a low point of the locked portion and the unlocked portion. The LFC can be moved in response to received input, and if the input is not sufficient to move the LFC from the locked region to the unlocked region, the LFC can be moved back down the positive-sloped lock track to the low point. The security component can control information to be displayed in an overlay display region in accordance with security level(s) of the device or application. | 04-14-2011 |
Domenico Maiorano, Saint-Martin De Londres FR
| Patent application number | Description | Published |
|---|---|---|
| 20080279855 | Dna Replication Modulating Peptides, Nucleic Acids Encoding Them, and Their Use in Pharmaceutical Compositions - The present invention relates to the use of a peptidic sequence which comprises or is constituted of a peptidic chain of at least contiguous amino acids selected from the amino acid sequence SEQ ID NO: 4, SEQ ID NO: 4 being delimited by the amino acid in position 76 and by the amino acid in position 160 of SEQ ID NO: 2 (human Geminin), provided that, if present, the flanking regions of the peptidic chain in the peptidic sequence are different from the flanking regions of the peptidic chain in SEQ ID NO: 2, for the preparation of a drug intended for the treatment or prevention of pathologies implying pathological DNA replication and/or differentiation disorders, or disturbance of the cellular proliferation/differentiation balance. | 11-13-2008 |
| 20090208938 | Use of the MCM8 Gene for the Preparation of a Pharmaceutical Composition - The use of the human or animal MCM8 gene coding for a DNA helicase, or parts of the gene, or transcripts thereof, or antisense nucleic acids able to hybridize with part of the transcripts, or silencing RNA derived from parts of the transcripts and able to repress the MCM8 gene, or proteins or peptidic fragments translated from the transcripts, or antibodies directed against the proteins or peptidic fragments for the preparation of a pharmaceutical composition for the treatment of a human or animal pathology linked to a dysfunction of the expression of the MCM8 gene, or of human or animal cancers. | 08-20-2009 |
| 20110023135 | USE OF A NEW GENE CODING FOR A NEW MEMBER OF THE MCM2-8 FAMILY IN PHARMACEUTICAL COMPOSITIONS - The use of the human or animal MCM9 gene, or parts of the gene, or transcripts thereof, or antisense nucleic acids able to hybridize with part of the gene or transcripts, or silencing RNA derived from parts of the transcripts and able to repress the MCM9 gene, or proteins or peptidic fragments translated from the transcripts, or antibodies directed against the proteins or peptidic fragments, for the preparation of a pharmaceutical composition for the treatment of a human or animal pathology linked to a dysfunction of the expression of the MCM9 gene, or of human or animal cancers. | 01-27-2011 |
Nick Maiorano, Montreal CA
| Patent application number | Description | Published |
|---|---|---|
| 20080214170 | System and Method of Updating Presence Information - A network node provides presence updates to mobile users. The node reduces the amount of network traffic by eliminating the need for explicit messaging used to inform a user of presence updates. Additionally, the node reduces network traffic by consolidating presence updates, and sending the user only changed portions of the presence information. | 09-04-2008 |
Vincenzo Maiorano, Galatina (lecce) IT
| Patent application number | Description | Published |
|---|---|---|
| 20090014070 | Electroactive device based on organic compounds, comprising a float-glass substrate - An electroactive photonic device (D) comprises a substrate ( | 01-15-2009 |
| 20110079772 | ORGANIC LIGHT-EMITTING DIODE WITH MICROCAVITY INCLUDING DOPED ORGANIC LAYERS AND FABRICATION PROCESS THEREOF - An organic light emitting diode (OLED) emitting light downward through a transparent substrate. The OLED embeds a microcavity formed between a cathode and an anode and includes a plurality of organic layers including a light emitting layer. The plurality of organic layers include at least a first layer made of an organic doped material aimed at enhancing the transport of electrons; and at least a second layer made of an organic doped material aimed at enhancing the transport of holes. The anode is obtained by deposition of a semitransparent layer of silver (Ag) over the transparent substrate to be directly in contact with the first doped organic layer. Then, thicknesses of the first and second doped organic layers can be freely adapted to best adjust the optical characteristics of the microcavity for the wavelength of monochromatic light to be produced by the OLED. | 04-07-2011 |